Prior authorization: turning a cost center into a competitive moat

Prior authorization (PA) is the tax every US specialty practice pays for the privilege of treating patients. The AMA's 2025 physician survey shows providers now complete an average of 43 PAs per physician per week, consuming roughly 14 hours of clinical and administrative time. For a 12-provider cardiology group, that's the equivalent of 4.2 full-time employees doing nothing but chasing payer approvals.

Most groups treat PA as an unavoidable cost of doing business. The groups that pull ahead in 2026 are treating it as a competitive moat: a place where operational discipline directly translates into faster care, higher patient throughput, and materially better financial performance. This playbook walks through the three changes that took a mid-size cardiology group from a 9.1-day PA turnaround to 2.3 days — in a single quarter.

Why PA is the leakiest process in specialty care

The core problem is structural: every payer wants the request in a different format, on a different portal, with different clinical documentation, in a different sequence. A group that treats 12 major payers is effectively running 12 parallel workflows — and staffing generalists to handle all of them.

The measurable consequences:

• 19% of all specialty-care denials are PA-related (CO-197/CO-198), and virtually all are preventable (AMA, 2025).
• 93% of physicians report PA delays interfere with patient care; 34% report a PA delay has led to a serious adverse event (AMA, 2025).
• Average PA turnaround across US specialty practices: 7–10 days. Top-decile operations run at 24–48 hours.
• Cost per PA request when processed by generalist staff: $11.10 per manual PA; specialist teams operating at density hit $3.80 (CAQH Index, 2025).

The mid-size cardiology group: baseline

The group profiled here — 12 cardiologists across three sites in the US Midwest — engaged our team with a PA process that looked textbook on paper and was quietly bleeding revenue in practice:

• Median PA turnaround: 9.1 days.
• PA-related denial rate: 16.4%.
• Same-day cancellations due to unresolved PA: ~28 per month, worth an estimated $340K in lost annual net revenue.
• Staffing: 3.5 FTE spread across sites, no payer specialization.

Baseline satisfaction with the PA function — internally — was at rock bottom. Schedulers didn't trust it, providers were routing around it, and the CFO couldn't answer basic questions about where in the funnel time was being lost.

Change #1 — Consolidate intake into a single shared queue

Site-based PA work is the enemy of throughput. Each site was building its own micro-backlog, and there was no visibility across the group into who was overloaded and who had slack. We consolidated all inbound PA requests into a single shared queue with SLA-based routing: rush cases (imaging within 48 hours) auto-routed to a dedicated escalation lane; routine cases into a FIFO lane with a hard 24-hour first-touch SLA.

Immediate effect: the average time from PA request created to first submission attempt dropped from 39 hours to 6 hours. That single change accounted for roughly 40% of the total cycle-time improvement.

Change #2 — Route payer-specific PAs to credentialed specialists

Generalists trying to master 12 payers master none of them. We restructured the team around payer verticals: two specialists dedicated to UHC and Cigna (the group's top two payers by PA volume), one for Aetna and BCBS regional plans, one for Medicare Advantage products, and a floating lead for the long tail.

Each specialist learned the quirks that generic staff never had time to internalize: which UHC MCG guideline actually gets applied to left-heart catheterization, which Cigna portal accepts DICOM attachments, which Aetna reviewer team is faster after 2pm EST. Within six weeks, first-pass PA approval on the top two payers moved from 67% to 91%.

Change #3 — Instrument a CARC-coded denial loop with weekly retraining

The third change was a governance discipline, not a workflow. Every PA denial was tagged with its CARC code, root cause, submitting user, and payer at the moment of denial. Every Friday, the team held a 30-minute PA huddle where the top three denial patterns from the week were reviewed with the specialists responsible.

The result was compound: denial patterns that would previously have persisted for months (a specific documentation requirement missed, a specific portal step skipped) were extinguished within one or two cycles. PA-related denials fell from 16.4% to 4.1% over the quarter.

The results — quarter over quarter

Metric	Baseline	End of Q1	Change
Median PA turnaround	9.1 days	2.3 days	−75%
PA-related denial rate	16.4%	4.1%	−75%
Same-day cancellations	28/mo	7/mo	−75%
PA FTE required	3.5	2.4	−31%
Recovered annual net revenue	—	~$412K	—

The provider satisfaction shift was, in some ways, the biggest change. Cardiologists stopped booking around the PA team; scheduling confidence recovered; the practice was able to add two additional imaging slots per day per site.

What made this work — and what to watch for

The playbook is transferable, but three preconditions matter:

• Leadership air-cover for consolidation. Site leaders will resist losing "their" PA person. Frame it as capacity, not control.
• A payer mix concentrated enough to specialize. If your top three payers are less than 60% of PA volume, hybrid specialization works better than full verticalization.
• A denial-tagging discipline the team actually uses. Untagged denials are invisible denials. Build the tag into the workflow, not as a post-hoc report.

Groups that ship all three see the same directional results within 60–90 days. The technology matters less than the operating discipline.

The competitive moat

Faster PA isn't just an operational win — it's a strategic one. Referring physicians route to specialists who can see their patients this week, not next month. Patients complete recommended imaging instead of dropping out of the pathway. Providers protect their schedules. Payers, ironically, prefer working with groups whose PA submissions are clean because it lowers their own review costs.

Prior authorization looks like a cost center. Run it well and it becomes one of the hardest-to-replicate advantages in specialty medicine.

If you're evaluating whether a similar sprint would work in your group, book a discovery call with our team or explore our Healthcare Solutions practice.